ARRY
Array Biopharma Inc
ARRY
ARRY
Delisted
ARRY was delisted on the 29th of July, 2019.
134 hedge funds and large institutions have $651M invested in Array Biopharma Inc in 2013 Q3 according to their latest regulatory filings, with 23 funds opening new positions, 43 increasing their positions, 41 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
0% more funds holding in top 10
Funds holding in top 10: 4 → 4 (0)
93% less call options, than puts
Call options by funds: $79K | Put options by funds: $1.08M
Holders
134
Holding in Top 10
4
Calls
$79K
Puts
$1.08M
Top Buyers
| 1 | +$15.8M | |
| 2 | +$14.5M | |
| 3 | +$11.9M | |
| 4 |
TCM
TimesSquare Capital Management
New York
|
+$9.11M |
| 5 |
State Street
Boston,
Massachusetts
|
+$7.68M |
Top Sellers
| 1 | -$8.78M | |
| 2 | -$8.38M | |
| 3 | -$6.84M | |
| 4 |
KIA
Kopp Investment Advisors
Bloomington,
Minnesota
|
-$4.84M |
| 5 |
CIP
Chartwell Investment Partners
Berywn,
Pennsylvania
|
-$4.75M |